Back to Search Start Over

The discovery of SB-435495: A potent, orally active inhibitor of lipoprotein-Associated phospholipase A2 for evaluation in man

Authors :
Blackie, Josie A.
Bloomer, Jackie C.
Brown, Murray J. B.
Cheng, Hung-Yuan
Elliott, Richard L.
Hammond, Beverley
Hickey, Deirdre M. B.
Ife, Robert J.
Leach, Colin A.
Lewis, V. Ann
Macphee, Colin H.
Milliner, Kevin J.
Moores, Kitty E.
Pinto, Ivan L.
Smith, Stephen A.
Stansfield, Ian G.
Stanway, Steven J.
Taylor, Maxine A.
Theobald, Colin J.
Whittaker, Caroline M.
Source :
Bioorganic & Medicinal Chemistry Letters. Sep2002, Vol. 12 Issue 18, p2603. 4p.
Publication Year :
2002

Abstract

The introduction of a functionalised amido substituent into a series of 1-(biphenylmethylacetamido)-pyrimidones has given a series of inhibitors of recombinant lipoprotein-associated phospholipase A2 with sub-nanomolar potency and very encouraging developability properties. Diethylaminoethyl derivative 32, SB-435495, was selected for progression to man. [Copyright &y& Elsevier]

Subjects

Subjects :
*LIPOPROTEINS
*PHOSPHOLIPASE A2

Details

Language :
English
ISSN :
0960894X
Volume :
12
Issue :
18
Database :
Academic Search Index
Journal :
Bioorganic & Medicinal Chemistry Letters
Publication Type :
Academic Journal
Accession number :
7860733
Full Text :
https://doi.org/10.1016/S0960-894X(02)00473-0